[8-K] Aveanna Healthcare Holdings, Inc. Reports Material Event

Rhea-AI Filing Summary

Aveanna Healthcare Holdings Inc. (AVAH) furnished an investor presentation under Regulation FD. On November 7, 2025, the company made a financial presentation available to investors, attached as Exhibit 99.1 to an 8‑K.

The materials are also posted in the Investors section of aveanna.com. The company states it uses its website to distribute important and time‑critical information. The information in Item 7.01, including Exhibit 99.1, is furnished and not filed, and is not subject to Section 18 liabilities or incorporated by reference unless specifically stated.

false000183233200018323322025-11-072025-11-07

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 07, 2025

Aveanna Healthcare Holdings Inc.

(Exact name of Registrant as Specified in Its Charter)

Delaware			001-40362	81-4717209
(State or Other Jurisdiction of Incorporation)			(Commission File Number)	(IRS Employer Identification No.)
400 Interstate North Parkway SE
Atlanta, Georgia				30339
(Address of Principal Executive Offices)				(Zip Code)

Registrant’s Telephone Number, Including Area Code: 770 441-1580

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, par value $0.01 per share		AVAH		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 7.01 Regulation FD Disclosure.

On November 7, 2025, Aveanna Healthcare Holdings Inc. (the "Company", "we", "us", or "our") made available a financial presentation to investors. A copy of the presentation is attached hereto as Exhibit 99.1 and incorporated by reference in this Item 7.01. A copy of the presentation is also available on our website at ir.aveanna.com.

Use of our Website and Social Media to Distribute Material Company Information

We use our website as a channel of distribution for important Company information. We routinely post on our website important information, including press releases, investor presentations and financial information, which may be accessed by clicking on the “Investors” section of www.aveanna.com. We also use our website to expedite public access to time-critical information regarding our Company in advance of or in lieu of distributing a press release or a filing with the SEC disclosing the same information. Therefore, investors should look to the “Investors” section of our website for important and time-critical information. Visitors to our website can also register to receive automatic e-mail and other notifications alerting them when certain new information is made available on our website. Information contained on, or accessible through, our website is not a part of and is not incorporated by reference in this Current Report on Form 8-K.

The information contained in this Item 7.01, including in Exhibit 99.1 attached hereto, is “furnished” and not “filed” for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section. Such information shall not be incorporated by reference in another filing under the Exchange Act or the Securities Act, except to the extent such other filing specifically incorporates such information by reference.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit Number		Description
99.1		Aveanna Investor Presentation - November 2025
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

			AVEANNA HEALTHCARE HOLDINGS INC.
Date:	November 7, 2025	By:	/s/ Matthew Buckhalter
			Matthew Buckhalter Chief Financial Officer (Principal Financial Officer)

FAQ

What did Aveanna (AVAH) disclose in this 8-K?

The company furnished a financial investor presentation under Regulation FD, attached as Exhibit 99.1.

Where can I access Aveanna’s November 2025 investor presentation?

It is attached as Exhibit 99.1 to the 8-K and available on the company’s website at ir.aveanna.com.

Is the information in the Aveanna 8-K furnished or filed?

The Item 7.01 information, including Exhibit 99.1, is furnished and not filed.

What does 'furnished, not filed' mean for Aveanna’s disclosure?

Furnished information is not subject to Section 18 liabilities and isn’t incorporated by reference unless expressly stated.

How does Aveanna distribute material company information?

Aveanna uses its website as a channel, posting press releases, investor presentations, and financial information in the Investors section.

Which exhibit numbers were included with the 8-K?

The filing includes Exhibit 99.1 (Investor Presentation - November 2025) and Exhibit 104 (Cover Page Inline XBRL).